Cargando…
867. Upregulated Matrix Metalloproteinase-2 Relates to Milder Hearing Impairment in Bacterial Meningitis
BACKGROUND: Hearing impairment is a well-recognized sequela caused by bacterial meningitis, but the underlying pathophysiology remains largely unknown. Matrix metalloproteinase-2 (MMP-2) is known to affect neuronal cell damage and survival in different diseases of the brain. We investigated whether...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252889/ http://dx.doi.org/10.1093/ofid/ofy209.052 |
_version_ | 1783373369137168384 |
---|---|
author | Savonius, Okko Roine, Irmeli Alassiri, Saeed Tervahartiala, Taina Helve, Otto Fernandez, Josefina Peltola, Heikki Sorsa, Timo Pelkonen, Tuula |
author_facet | Savonius, Okko Roine, Irmeli Alassiri, Saeed Tervahartiala, Taina Helve, Otto Fernandez, Josefina Peltola, Heikki Sorsa, Timo Pelkonen, Tuula |
author_sort | Savonius, Okko |
collection | PubMed |
description | BACKGROUND: Hearing impairment is a well-recognized sequela caused by bacterial meningitis, but the underlying pathophysiology remains largely unknown. Matrix metalloproteinase-2 (MMP-2) is known to affect neuronal cell damage and survival in different diseases of the brain. We investigated whether levels of MMP-2 in the cerebrospinal fluid (CSF) relate to the extent of hearing impairment in children with bacterial meningitis. METHODS: Clinical data of 179 children were obtained from a previous clinical trial examining the adjuvant treatment of bacterial meningitis in Latin America in 1996–2003. At discharge or shortly thereafter, the ability to hear was measured with brain stem evoked response audiometry or traditional pure tone audiometry. Levels of CSF MMP-2 on admission (CSF1, n = 161) and 12–24 hours later (CSF2, n = 133) were assessed by zymography. The combined results for the detected pro-form and active MMP-2 were compared with the audiological outcome of the patients. RESULTS: MMP-2 was detected in half of both the CSF1 and CSF2 samples. The median densitometric values with interquartile ranges (IQRs) were 0.04 (IQR 0.00–0.29) for CSF1 and 0.00 (IQR 0.00–0.33) for CSF2. Detectable MMP-2 associated with milder hearing impairment in CSF1 (P = 0.05), but not in CSF2 (P = 0.1). Patients who were deaf at discharge had lower levels of MMP-2 in both samples (CSF1, P = 0.05; CSF2, P = 0.04), compared with patients who were not deaf. A MMP-2 level over the 75th percentile in CSF1 predicted lower odds of any audiological sequelae (odds ratio 0.30, 95% confidence interval 0.14–0.68, P = 0.004). CONCLUSION: The upregulation of MMP-2 in the CSF associated with a better audiological outcome in children with bacterial meningitis. The results suggest that MMP-2 might play a protective role in the development of hearing sequelae due to bacterial meningitis. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6252889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62528892018-11-28 867. Upregulated Matrix Metalloproteinase-2 Relates to Milder Hearing Impairment in Bacterial Meningitis Savonius, Okko Roine, Irmeli Alassiri, Saeed Tervahartiala, Taina Helve, Otto Fernandez, Josefina Peltola, Heikki Sorsa, Timo Pelkonen, Tuula Open Forum Infect Dis Abstracts BACKGROUND: Hearing impairment is a well-recognized sequela caused by bacterial meningitis, but the underlying pathophysiology remains largely unknown. Matrix metalloproteinase-2 (MMP-2) is known to affect neuronal cell damage and survival in different diseases of the brain. We investigated whether levels of MMP-2 in the cerebrospinal fluid (CSF) relate to the extent of hearing impairment in children with bacterial meningitis. METHODS: Clinical data of 179 children were obtained from a previous clinical trial examining the adjuvant treatment of bacterial meningitis in Latin America in 1996–2003. At discharge or shortly thereafter, the ability to hear was measured with brain stem evoked response audiometry or traditional pure tone audiometry. Levels of CSF MMP-2 on admission (CSF1, n = 161) and 12–24 hours later (CSF2, n = 133) were assessed by zymography. The combined results for the detected pro-form and active MMP-2 were compared with the audiological outcome of the patients. RESULTS: MMP-2 was detected in half of both the CSF1 and CSF2 samples. The median densitometric values with interquartile ranges (IQRs) were 0.04 (IQR 0.00–0.29) for CSF1 and 0.00 (IQR 0.00–0.33) for CSF2. Detectable MMP-2 associated with milder hearing impairment in CSF1 (P = 0.05), but not in CSF2 (P = 0.1). Patients who were deaf at discharge had lower levels of MMP-2 in both samples (CSF1, P = 0.05; CSF2, P = 0.04), compared with patients who were not deaf. A MMP-2 level over the 75th percentile in CSF1 predicted lower odds of any audiological sequelae (odds ratio 0.30, 95% confidence interval 0.14–0.68, P = 0.004). CONCLUSION: The upregulation of MMP-2 in the CSF associated with a better audiological outcome in children with bacterial meningitis. The results suggest that MMP-2 might play a protective role in the development of hearing sequelae due to bacterial meningitis. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6252889/ http://dx.doi.org/10.1093/ofid/ofy209.052 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Savonius, Okko Roine, Irmeli Alassiri, Saeed Tervahartiala, Taina Helve, Otto Fernandez, Josefina Peltola, Heikki Sorsa, Timo Pelkonen, Tuula 867. Upregulated Matrix Metalloproteinase-2 Relates to Milder Hearing Impairment in Bacterial Meningitis |
title | 867. Upregulated Matrix Metalloproteinase-2 Relates to Milder Hearing Impairment in Bacterial Meningitis |
title_full | 867. Upregulated Matrix Metalloproteinase-2 Relates to Milder Hearing Impairment in Bacterial Meningitis |
title_fullStr | 867. Upregulated Matrix Metalloproteinase-2 Relates to Milder Hearing Impairment in Bacterial Meningitis |
title_full_unstemmed | 867. Upregulated Matrix Metalloproteinase-2 Relates to Milder Hearing Impairment in Bacterial Meningitis |
title_short | 867. Upregulated Matrix Metalloproteinase-2 Relates to Milder Hearing Impairment in Bacterial Meningitis |
title_sort | 867. upregulated matrix metalloproteinase-2 relates to milder hearing impairment in bacterial meningitis |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252889/ http://dx.doi.org/10.1093/ofid/ofy209.052 |
work_keys_str_mv | AT savoniusokko 867upregulatedmatrixmetalloproteinase2relatestomilderhearingimpairmentinbacterialmeningitis AT roineirmeli 867upregulatedmatrixmetalloproteinase2relatestomilderhearingimpairmentinbacterialmeningitis AT alassirisaeed 867upregulatedmatrixmetalloproteinase2relatestomilderhearingimpairmentinbacterialmeningitis AT tervahartialataina 867upregulatedmatrixmetalloproteinase2relatestomilderhearingimpairmentinbacterialmeningitis AT helveotto 867upregulatedmatrixmetalloproteinase2relatestomilderhearingimpairmentinbacterialmeningitis AT fernandezjosefina 867upregulatedmatrixmetalloproteinase2relatestomilderhearingimpairmentinbacterialmeningitis AT peltolaheikki 867upregulatedmatrixmetalloproteinase2relatestomilderhearingimpairmentinbacterialmeningitis AT sorsatimo 867upregulatedmatrixmetalloproteinase2relatestomilderhearingimpairmentinbacterialmeningitis AT pelkonentuula 867upregulatedmatrixmetalloproteinase2relatestomilderhearingimpairmentinbacterialmeningitis |